CorMedix Inc. - Common Stock (CRMD)

Cormedix Inc is a biopharmaceutical company focused on developing innovative therapies aimed at improving the lives of patients with serious medical conditions

The company primarily concentrates on treatments for infections related to catheter use and other healthcare-associated infections. Cormedix is dedicated to advancing its proprietary product candidates through clinical trials and regulatory pathways, with an emphasis on addressing unmet medical needs in the fields of nephrology and infectious diseases. Through its research and development efforts, Cormedix aims to provide effective and safe therapeutic solutions that enhance patient outcomes.